Guidelines for the management of chronic kidney disease

被引:260
作者
Levin, Adeera [1 ]
Hemmelgarn, Brenda [2 ]
Culleton, Bruce [2 ]
Tobe, Sheldon [6 ]
McFarlane, Philip [6 ]
Ruzicka, Marcel [7 ]
Burns, Kevin [7 ]
Manns, Braden [2 ]
White, Colin [1 ]
Madore, Francoise [9 ]
Moist, Louise [8 ]
Klarenbach, Scott [3 ]
Barrett, Brendan [11 ]
Foley, Robert [12 ]
Jindal, Kailash [3 ]
Senior, Peter [3 ]
Pannu, Neesh [3 ]
Shurraw, Sabin [3 ]
Akbari, Ayub [7 ]
Cohn, Adam [7 ]
Reslerova, Martina [5 ]
Deved, Vinay [2 ]
Mendelssohn, David [10 ]
Nesrallah, Gihad [10 ]
Kappel, Joanne [4 ]
Tonelli, Marcello [3 ]
机构
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Univ Calgary, Calgary, AB, Canada
[3] Univ Alberta, Edmonton, AB, Canada
[4] Univ Saskatchewan, Saskatoon, SK, Canada
[5] Univ Manitoba, Winnipeg, MB, Canada
[6] Univ Toronto, Toronto, ON, Canada
[7] Univ Ottawa, Ottawa, ON, Canada
[8] Univ Western Ontario, London, England
[9] Univ Montreal, Montreal, PQ, Canada
[10] Humber River Reg Hosp, Toronto, ON, Canada
[11] Mem Univ, St John, NF, Canada
[12] Univ Minnesota, Minneapolis, MN USA
关键词
D O I
10.1503/cmaj.080351
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1154 / 1162
页数:9
相关论文
共 70 条
[1]   Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients [J].
Allon, M ;
Lockhart, ME ;
Lilly, RZ ;
Gallichio, MH ;
Young, CT ;
Barker, J ;
Deierhoi, MH ;
Robbin, ML .
KIDNEY INTERNATIONAL, 2001, 60 (05) :2013-2020
[2]  
[Anonymous], 2008, Can J Diabetes, V32, pS1
[3]   First united kingdom heart and renal protection (UK-HARP-1) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease [J].
Baigent, C ;
Landray, M ;
Leaper, C ;
Altmann, P ;
Armitage, J ;
Baxter, A ;
Cairns, HS ;
Collins, R ;
Foley, RN ;
Frighi, V ;
Kourellias, K ;
Ratcliffe, PJ ;
Rogerson, M ;
Scoble, JE ;
Tomson, CRV ;
Warwick, G ;
Wheeler, DC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (03) :473-484
[4]   PROTEINURIA - PATHOPHYSIOLOGY, SIGNIFICANCE AND RECOMMENDATIONS FOR MEASUREMENT IN CLINICAL-PRACTICE [J].
BEETHAM, R ;
CATTELL, WR .
ANNALS OF CLINICAL BIOCHEMISTRY, 1993, 30 :425-434
[5]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[6]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[7]   Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis [J].
Charytan, C ;
Qunibi, W ;
Bailie, GR .
NEPHRON CLINICAL PRACTICE, 2005, 100 (03) :C55-C62
[8]   Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].
Chaturvedi, N .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379
[9]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[10]   Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12